Mag. Oliver Eberhardt

Prof. Solange Peters, MD, PhD, CHUV Lausanne, puts the research she presented at ESMO 2019 in perspective by explaining the complex CheckMate 227 trial and giving an update on the NICOLAS trial.

Prof. Reinhard Dummer, MD, University Hospital Zurich, and Prof. Olivier Michielin, MD, PhD, CHUV Lausanne, discuss the current advances and challenges in melanoma treatment with a focus on immunotherapy.

In this year's Scientific Knowledge Exchange, Prof. Dr. Reinhard Dummer, University Hospital of Zurich, and Prof. Dr. Olivier Michielin, University Hospital of Lausanne, discuss ASCO 2019’s news in melanoma research and therapy.

PD Dr. Richard Cathomas, Kantonsspital Chur, Graubünden, talks about the most interesting studies in genitourinary cancers presented at this year's ASCO.

In this Breakfast Brief Prof. Dr. Solange Peters, Central University Hospital (CHUV) in Lausanne, presents new and noteworthy trials dominating current discussions in lung cancer.

PD DDr. Sacha Rothschild, University Hospital Basel, comments on this year's head and neck cancer studies, as well as lung cancer trials.

The medonline team was present at ESMO 2018 to learn about recent developments in Oncology, and to get to know the opinion of renownend experts of the field of how they think these new data will affect the current treatment standards.

Dr. Claudia Cardone, Università Vanvitelli in Naples, Italy, is currently a research fellow at the Medical University of Vienna to investigate biomarkers in CRC. She also describes what ESMO young oncologists can do for "youngsters".